Real-World Safety of Intravitreal Bevacizumab and Ranibizumab Treatments for Retinal Diseases in Thailand: A Prospective Observational Study

BACKGROUND: There is very limited evidence examining serious systemic adverse events (SSAEs) and post-injection endophthalmitis of intravitreal bevacizumab (IVB) and intravitreal ranibizumab (IVR) treatments in Thailand and low- and middle-income countries. Moreover, findings from the existing trial...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Drug Investig
Main Authors: Sangroongruangsri, Sermsiri, Chaikledkaew, Usa, Kumluang, Suthasinee, Wu, Olivia, Geue, Claudia, Ratanapakorn, Tanapat, Leelahavarong, Pattara, Ingsrisawang, Lily, Ruamviboonsuk, Paisan, Taweebanjongsin, Wongsiri, Choovuthayakorn, Janejit, Singalavanija, Apichart, Hanutsaha, Prut, Kulvichit, Kittisak, Ratanapojnard, Thitiporn, Wongsawad, Warapat, Teerawattananon, Yot
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2018
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6153972/
https://ncbi.nlm.nih.gov/pubmed/30069864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-018-0678-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados